Skip to main content

. 1997 Jun;50(6):534. doi: 10.1136/jcp.50.6.534

Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.

M Sur, L Taylor, K Cooper, R K Sur

PMCID: PMC500009 PMID: 9378827

534

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Darnton S. J., Jenner K., Steyn R. S., Ferry D. R., Matthews H. R. Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer. J Clin Pathol. 1995 Nov;48(11):1064–1066. doi: 10.1136/jcp.48.11.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
Glazer R. I., Rohlff C. Transcriptional regulation of multidrug resistance in breast cancer. Breast Cancer Res Treat. 1994;31(2-3):263–271. doi: 10.1007/BF00666159. [DOI] [PubMed] [Google Scholar]
Linn S. C., Giaccone G. MDR1/P-glycoprotein expression in colorectal cancer. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1291–1294. doi: 10.1016/0959-8049(95)00278-q. [DOI] [PubMed] [Google Scholar]
Mannell A., Murray W. Oesophageal cancer in South Africa. A review of 1926 cases. Cancer. 1989 Dec 15;64(12):2604–2608. doi: 10.1002/1097-0142(19891215)64:12<2604::aid-cncr2820641233>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
Mickisch G. H. Chemoresistance of renal cell carcinoma: 1986-1994. World J Urol. 1994;12(4):214–223. doi: 10.1007/BF00185677. [DOI] [PubMed] [Google Scholar]
Scher H. I. Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results. Urol Clin North Am. 1992 Nov;19(4):747–759. [PubMed] [Google Scholar]
Sekiya S., Nunoyama T., Shirasawa H., Kimura H., Kawata M., Iijima N., Sugimoto Y., Tsuruo T., Takamizawa H. Expression of a human multidrug resistance gene in human ovarian carcinoma cell lines. Arch Gynecol Obstet. 1992;251(2):79–86. doi: 10.1007/BF02759915. [DOI] [PubMed] [Google Scholar]
Sur M., Sur R., Cooper K., Levin V., Bizos D., Dubazana N. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy. Cancer. 1996 Jun 1;77(11):2200–2205. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2200::AID-CNCR3>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
Wallner J., Depisch D., Gsur A., Götzl M., Haider K., Pirker R. MDR1 gene expression and its clinical relevance in primary gastric carcinomas. Cancer. 1993 Feb 1;71(3):667–671. doi: 10.1002/1097-0142(19930201)71:3<667::aid-cncr2820710303>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES